Dual-compound stack combining a GH secretagogue (Ibutamoren/MK-677) with a selective androgen receptor modulator (LGD-4033) for controlled studies into lean-mass retention, recovery frameworks, and recomposition models.
Product Features & Specifications
-
Per capsule: MK-677 (Ibutamoren) 10 mg • LGD-4033 (Ligandrol) 4 mg
-
Form: Encapsulated research compounds — 60 capsules
-
Excipients: Research-grade fillers/flow agents • Capsule: HPMC
-
Purity: ≥98% (HPLC; batch-dependent)
-
Storage: Store cool, dry, away from light; keep sealed
Compound Reference (for researchers)
-
Ibutamoren (MK-677): ghrelin-receptor agonist used to study GH/IGF-1 axis, sleep architecture, and body-composition markers
-
LGD-4033 (Ligandrol): tissue-selective AR modulator explored for lean body mass and strength proxies
Research Applications
-
Convergent signalling: AR modulation + GH/IGF-1 pathways
-
Deficit/cutting models: muscle-preservation proxies
-
Performance & recovery: work capacity and post-exercise recovery frameworks
-
Stacking studies: foundation for multi-compound protocols
Compliance & Safety
For laboratory research only. Not a food, supplement, or medicine. Not for human or veterinary consumption. Handle with appropriate lab PPE under institutional SOPs and local regulations. Keep out of reach of children.